Comparison of the effectiveness of Martin's equation, Friedewald's equation, and a Novel equation in low-density lipoprotein cholesterol estimation
- PMID: 34188076
- PMCID: PMC8241859
- DOI: 10.1038/s41598-021-92625-x
Comparison of the effectiveness of Martin's equation, Friedewald's equation, and a Novel equation in low-density lipoprotein cholesterol estimation
Abstract
Low-density-lipoprotein cholesterol (LDL-C) is the main target in atherosclerotic cardiovascular disease (ASCVD). We aimed to validate and compare a new LDL-C estimation equation with other well-known equations. 177,111 samples were analysed from two contemporary population-based cohorts comprising asymptomatic Korean adults who underwent medical examinations. Performances of the Friedewald (FLDL), Martin (MLDL), and Sampson (SLDL) equations in estimating direct LDL-C by homogenous assay were assessed by measures of concordance (R2, RMSE, and mean absolute difference). Analyses were performed according to various triglyceride (TG) and/or LDL-C strata. Secondary analyses were conducted within dyslipidaemia populations of each database. MLDL was superior or at least similar to other equations regardless of TG/LDL-C, in both the general and dyslipidaemia populations (RMSE = 11.45/9.20 mg/dL; R2 = 0.88/0.91; vs FLDL: RMSE = 13.66/10.42 mg/dL; R2 = 0.82/0.89; vs SLDL: RMSE = 12.36/9.39 mg/dL; R2 = 0.85/0.91, per Gangnam Severance Hospital Check-up/Korea Initiatives on Coronary Artery Calcification data). MLDL had a slight advantage over SLDL with the lowest MADs across the full spectrum of TG levels, whether divided into severe hyper/non-hyper to moderate hypertriglyceridaemia samples or stratified by 100-mg/dL TG intervals, even up to TG values of 500-600 mg/dL. MLDL may be a readily adoptable and cost-effective alternative to direct LDL-C measurement, irrespective of dyslipidaemia status. In populations with relatively high prevalence of mild-to-moderate hypertriglyceridaemia, Martin's equation may be optimal for LDL-C and ASCVD risk estimation.
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Comparative assessment of LDL-C and VLDL-C estimation in familial combined hyperlipidemia using Sampson's, Martin's and Friedewald's equations.Lipids Health Dis. 2021 May 5;20(1):46. doi: 10.1186/s12944-021-01471-3. Lipids Health Dis. 2021. PMID: 33952259 Free PMC article.
-
Comparison of Various Low Density Lipoprotein Cholesterol Calculators: Is It Time for the Friedewald Equation to Go in India?J Assoc Physicians India. 2024 Sep;72(9):e1-e5. doi: 10.59556/japi.72.0645. J Assoc Physicians India. 2024. PMID: 39291520
-
Usefulness of the Martin Method for Estimation of Low-Density Lipoprotein Cholesterol in Coronary Atherosclerosis.Med Princ Pract. 2018;27(1):8-14. doi: 10.1159/000485977. Epub 2017 Dec 4. Med Princ Pract. 2018. PMID: 29202484 Free PMC article.
-
Accuracy of 23 Equations for Estimating LDL Cholesterol in a Clinical Laboratory Database of 5,051,467 Patients.Glob Heart. 2023 Jun 19;18(1):36. doi: 10.5334/gh.1214. eCollection 2023. Glob Heart. 2023. PMID: 37361322 Free PMC article.
-
Update on low-density lipoprotein cholesterol quantification.Curr Opin Lipidol. 2019 Aug;30(4):273-283. doi: 10.1097/MOL.0000000000000611. Curr Opin Lipidol. 2019. PMID: 31135594 Review.
Cited by
-
Validation of low-density lipoprotein cholesterol equations in pediatric population.PeerJ. 2023 Jan 5;11:e14544. doi: 10.7717/peerj.14544. eCollection 2023. PeerJ. 2023. PMID: 36627923 Free PMC article.
-
Evaluation of current indirect methods for measuring LDL-cholesterol.Clin Chem Lab Med. 2025 Feb 19;63(6):1099-1108. doi: 10.1515/cclm-2025-0024. Print 2025 May 26. Clin Chem Lab Med. 2025. PMID: 39964360
-
Comparison of Estimated LDL Cholesterol Equations with Direct Measurement in Patients with Angiographically Confirmed Coronary Artery Disease.J Cardiovasc Dev Dis. 2022 Oct 7;9(10):342. doi: 10.3390/jcdd9100342. J Cardiovasc Dev Dis. 2022. PMID: 36286294 Free PMC article.
-
Novel Biomarkers for Atherosclerotic Disease: Advances in Cardiovascular Risk Assessment.Life (Basel). 2023 Jul 27;13(8):1639. doi: 10.3390/life13081639. Life (Basel). 2023. PMID: 37629496 Free PMC article. Review.
-
Fatigued with Friedewald: why isn't everyone onboard yet with the new LDL-C equations?Front Cardiovasc Med. 2025 Feb 27;12:1534460. doi: 10.3389/fcvm.2025.1534460. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40083824 Free PMC article. No abstract available.
References
-
- Grundy SM, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J. Am. Coll. Cardiol. 2019;73:e285–e350. doi: 10.1016/j.jacc.2018.11.003. - DOI - PubMed
-
- Arnett DK, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J. Am. Coll. Cardiol. 2019;74:1376–1414. doi: 10.1016/j.jacc.2019.03.009. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous